Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
KURA
#2246
Kura Oncology, Inc.
8.7
3
+4.30%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+4.30%
Variazione Mensile
+3.44%
Variazione di 6 mesi
+9.54%
Variazione Annuale
+14.87%
Chiusura Precedente
8.3
7
Open
8.7
3
Bid
Ask
Low
8.7
3
High
8.7
3
Volume
85
Mercati
Mercato Azionario Statunitense
Salute
KURA
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
—
Valuation ratios
Enterprise value
1.84 B
841.93 M
772.88 M
1.13 B
478.91 M
2.09 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-13.62
Price to sales ratio
—
—
—
—
13.93
—
Price to cash flow ratio
—
—
-7.33
-9.01
5.59
23.04
Price to book ratio
—
—
1.92
2.83
1.81
3.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.14
0.24
0.3
0.34
0.23
0.31
Return on equity %
0.15
0.26
0.32
0.38
0.42
0.73
Return on invested capital %
-4 731.27
-4 247.5
-4 669.95
-4 398.28
2 520.1
2 898.67
Gross margin %
—
100
—
—
100
—
Operating margin %
—
-61.81 K
—
—
358.55
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
61.54 K
—
—
322.89
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.49
23.26
18.56
12.26
9.46
28.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
—
—
0.09
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.01
0.02
0.02
0.01
0.04
Long term debt to total equity ratio
0.01
0.01
0.02
0.02
0.02
0.08
Per share metrics
Operating cash flow per share
—
—
1.64
1.7
1.56
2.07
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
6.54
5.79
8.44
29.44
Net current asset value per share
—
—
6.66
5.91
8.64
31.55
Tangible book value per share
—
—
6.27
5.43
4.8
15.22
Working capital per share
—
—
6.3
5.42
7.73
27
Book value per share
—
—
6.27
5.43
4.8
15.22
Notizie
Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline
Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline
Citizens conferma il rating Market Outperform per le azioni di Kura Oncology
Citizens reiterates Market Outperform rating on Kura Oncology stock
Kura Oncology’s chief legal officer sells $94,827 in stock
Il CCO di Kura Oncology Powl vende titoli per $54.266
Kura Oncology CCO Powl sells $54,266 in stock
Il CSO di Kura Oncology Burrows vende azioni per 11mila dollari
Il direttore medico di Kura Oncology, Leoni, vende azioni per 69.000 dollari
Kura Oncology SVP sells $60k in shares
Kura Oncology COO Ford sells $15,339 in stock
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock